Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiniksa Pharmaceuticals International (KNSA) Depreciation and Depletion (2021 - 2025)

Historic Depreciation and Depletion for Kiniksa Pharmaceuticals International (KNSA) over the last 5 years, with Q3 2025 value amounting to $27000.0.

  • Kiniksa Pharmaceuticals International's Depreciation and Depletion fell 6896.55% to $27000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $163000.0, marking a year-over-year decrease of 7265.1%. This contributed to the annual value of $448000.0 for FY2024, which is 5960.32% down from last year.
  • As of Q3 2025, Kiniksa Pharmaceuticals International's Depreciation and Depletion stood at $27000.0, which was down 6896.55% from $13000.0 recorded in Q2 2025.
  • Kiniksa Pharmaceuticals International's 5-year Depreciation and Depletion high stood at $416000.0 for Q2 2021, and its period low was $13000.0 during Q2 2025.
  • Its 5-year average for Depreciation and Depletion is $224578.9, with a median of $289000.0 in 2023.
  • Its Depreciation and Depletion has fluctuated over the past 5 years, first soared by 6497.18% in 2023, then tumbled by 8907.56% in 2025.
  • Kiniksa Pharmaceuticals International's Depreciation and Depletion (Quarter) stood at $376000.0 in 2021, then fell by 21.81% to $294000.0 in 2022, then decreased by 19.73% to $236000.0 in 2023, then crashed by 62.71% to $88000.0 in 2024, then crashed by 69.32% to $27000.0 in 2025.
  • Its Depreciation and Depletion stands at $27000.0 for Q3 2025, versus $13000.0 for Q2 2025 and $35000.0 for Q1 2025.